Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Cash from Investing Activities
Abbott Laboratories
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-3%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Investing Activities
-$658m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
4%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Investing Activities
-$2.6B
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-18%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash from Investing Activities
$173.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Cash from Investing Activities
-$962m
|
CAGR 3-Years
41%
|
CAGR 5-Years
20%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
See Also
What is Abbott Laboratories's Cash from Investing Activities?
Cash from Investing Activities
-3.1B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Cash from Investing Activities amounts to -3.1B USD.
What is Abbott Laboratories's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-3%
Over the last year, the Cash from Investing Activities growth was -70%. The average annual Cash from Investing Activities growth rates for Abbott Laboratories have been -12% over the past three years , -16% over the past five years , and -3% over the past ten years .